These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17. Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483 [TBL] [Abstract][Full Text] [Related]
27. Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles. Schumacher N; Meyer D; Mauermann A; von der Heyde J; Wolf J; Schwarz J; Knittler K; Murphy G; Michalek M; Garbers C; Bartsch JW; Guo S; Schacher B; Eickholz P; Chalaris A; Rose-John S; Rabe B J Biol Chem; 2015 Oct; 290(43):26059-71. PubMed ID: 26359498 [TBL] [Abstract][Full Text] [Related]
28. Human P2X7 receptor activation induces the rapid shedding of CXCL16. Pupovac A; Foster CM; Sluyter R Biochem Biophys Res Commun; 2013 Mar; 432(4):626-31. PubMed ID: 23428418 [TBL] [Abstract][Full Text] [Related]
29. The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding. Maretzky T; Evers A; Le Gall S; Alabi RO; Speck N; Reiss K; Blobel CP J Biol Chem; 2015 Mar; 290(12):7416-25. PubMed ID: 25605720 [TBL] [Abstract][Full Text] [Related]
30. Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding. Garbers C; Jänner N; Chalaris A; Moss ML; Floss DM; Meyer D; Koch-Nolte F; Rose-John S; Scheller J J Biol Chem; 2011 Apr; 286(17):14804-11. PubMed ID: 21454673 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of the metalloproteinases ADAM10 or ADAM17 promotes osteoclast differentiation. Babendreyer A; Kieselhorst J; Rinkens C; Lyashenko AM; Düsterhöft S; Jahr H; Craveiro RB; Wolf M; Ludwig A Cell Commun Signal; 2024 Jun; 22(1):322. PubMed ID: 38863060 [TBL] [Abstract][Full Text] [Related]
32. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition. Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140 [TBL] [Abstract][Full Text] [Related]
33. Hydrogen peroxide and endothelin-1 are novel activators of betacellulin ectodomain shedding. Sanderson MP; Abbott CA; Tada H; Seno M; Dempsey PJ; Dunbar AJ J Cell Biochem; 2006 Oct; 99(2):609-23. PubMed ID: 16676357 [TBL] [Abstract][Full Text] [Related]
34. ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes. Condon TP; Flournoy S; Sawyer GJ; Baker BF; Kishimoto TK; Bennett CF Antisense Nucleic Acid Drug Dev; 2001 Apr; 11(2):107-16. PubMed ID: 11334139 [TBL] [Abstract][Full Text] [Related]
35. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). Matthews V; Schuster B; Schütze S; Bussmeyer I; Ludwig A; Hundhausen C; Sadowski T; Saftig P; Hartmann D; Kallen KJ; Rose-John S J Biol Chem; 2003 Oct; 278(40):38829-39. PubMed ID: 12832423 [TBL] [Abstract][Full Text] [Related]
36. Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure. Fahrenholz F; Gilbert S; Kojro E; Lammich S; Postina R Ann N Y Acad Sci; 2000; 920():215-22. PubMed ID: 11193153 [TBL] [Abstract][Full Text] [Related]
37. ADAM10 and ADAM17 proteases mediate proinflammatory cytokine-induced and constitutive cleavage of endomucin from the endothelial surface. Yang J; LeBlanc ME; Cano I; Saez-Torres KL; Saint-Geniez M; Ng YS; D'Amore PA J Biol Chem; 2020 May; 295(19):6641-6651. PubMed ID: 32193206 [TBL] [Abstract][Full Text] [Related]
38. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. Vincent B; Paitel E; Saftig P; Frobert Y; Hartmann D; De Strooper B; Grassi J; Lopez-Perez E; Checler F J Biol Chem; 2001 Oct; 276(41):37743-6. PubMed ID: 11477090 [TBL] [Abstract][Full Text] [Related]
39. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries. Tucher J; Linke D; Koudelka T; Cassidy L; Tredup C; Wichert R; Pietrzik C; Becker-Pauly C; Tholey A J Proteome Res; 2014 Apr; 13(4):2205-14. PubMed ID: 24635658 [TBL] [Abstract][Full Text] [Related]
40. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]